Circulomics Inc.

Baltimore, MD · Biotech · Private

Short Read Eliminator (SRE) size selection technology using proprietary polymer chemistries for high molecular weight DNA purification and size selection

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · circulomics.com

Sector: Biotech
Headquarters: Baltimore, MD
Total capital: $13.8M

Federal grants: $13.8M; 18 awards · 2015–2021; Rank in peer group#14 of 42
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: $19K; 1 award · Agriculture; Rank in Biotech#372 of 4373
Granted patents: 4; 5 pending · first 2020; Rank in peer group#10 of 42

Capital timeline

Latest events

Sep 2021Federal contractAgriculture · Attn: Linda W. Washington Circulomics Asf Order$19K
Jul 2021Federal grantHealth and Human S · Phase II · Rapid Method to Enhance and Shape Long-Read Sequencing Read Length Distributions$1
Sep 2020Federal grantHealth and Human S · Phase II · Nanostructured Magnetic Disks for Wide Range Size Selection in NGS Library Preparation and PCR Purification$411K
Aug 2020Federal grantHealth and Human S · Phase II · Rapid Method to Enhance and Shape Long-Read Sequencing Read Length Distributions$1.6M
Aug 2020Federal grantHealth and Human S · Phase II · Rapid Method to Enhance and Shape Long-Read Sequencing Read Length Distributions$859K
Mar 2020Federal grantHealth and Human S · Phase II · Nanostructured Magnetic Disks for Wide Range Size Selection in NGS Library Preparation and PCR Purification$737K
Mar 2019Federal grantHealth and Human S · Phase II · Nanostructured Magnetic Disks for Wide Range Size Selection in NGS Library Preparation and PCR Purification$744K

Show 12 earlier federal awards

Aug 2018Federal grantHealth and Human S · Phase II · High Quality, High Integrity Nucleic Acid Extraction from FFPE Tissues$737K
Jan 2018Federal grantHealth and Human S · Phase II · PicoSep - A Microfluidic Platform for Single Molecule DNA and RNA Sizing$745K
Sep 2017Federal grantHealth and Human S · Phase II · High Quality, High Integrity Nucleic Acid Extraction from FFPE Tissues$1.5M
Sep 2017Federal grantHealth and Human S · Phase II · High Quality, High Integrity Nucleic Acid Extraction from FFPE Tissues$759K
Aug 2017Federal grantHealth and Human S · Phase I · Size Selection Purification Using a Thermoplastic Silica Nanomaterial$224K
Aug 2017Federal grantHealth and Human S · Phase I · Size Selection Purification Using a Thermoplastic Silica Nanomaterial$224K
Jan 2017Federal grantHealth and Human S · Phase II · PicoSep - A Microfluidic Platform for Single Molecule DNA and RNA Sizing$746K
Aug 2016Federal grantHealth and Human S · Phase II · Nanobind Hierarchical Silica Lamella for High Molecular Weight DNA Extraction$749K
Jun 2016Federal grantHealth and Human S · Phase II · Ligo-miR - A Multiplex Assay Platform for Targeted miRNA Profiling$749K
Sep 2015Federal grantHealth and Human S · Phase II · Nanobind Hierarchical Silica Lamella for High Molecular Weight DNA Extraction$749K
May 2015Federal grantHealth and Human S · Phase II · Ligo-miR - A Multiplex Assay Platform for Targeted miRNA Profiling$1.5M
May 2015Federal grantHealth and Human S · Phase II · Ligo-miR - A Multiplex Assay Platform for Targeted miRNA Profiling$749K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 42 peers

Line = median

Biotech · Instrument

Federal grants#14 · top 33%
Granted patents#10 · top 24%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 4 granted of 9

Sep 10, 2024GrantedHierarchical Silica Lamella For Magnetic Nucleic Acid ExtractionsUSPTOUS 12,083,534
Aug 22, 2023GrantedSize Selection Purification Using A Thermoplastic Silica NanomaterialUSPTOUS 11,732,254
Dec 14, 2021GrantedHierarchical Silica Lamella For Magnetic Nucleic Acid ExtractionUSPTOUS 11,198,135

Show all 9 patent records

Hierarchical Silica Lamella For Magnetic Nucleic Acid ExtractionsSep 10, 2024 · US 12,083,534Granted
Size Selection Purification Using A Thermoplastic Silica NanomaterialAug 22, 2023 · US 11,732,254Granted
Hierarchical Silica Lamella For Magnetic Nucleic Acid ExtractionDec 14, 2021 · US 11,198,135Granted
Hierarchical Silica Lamella For Magnetic Nucleic Acid ExtractionAug 11, 2020 · US 10,737,276Granted
Hierarchical Silica Lamella For Magnetic Nucleic Acid ExtractionApplication PCTUS2016014920Pending
Hierarchical Silica Lamella for Magnetic Nucleic Acid ExtractionApplication 62108288Pending
Rapid Precipitation-driven Kilobase Size Selection Of Hmw DnaApplication 62947969Pending
Size Selection Purification Using A Thermoplastic Silica NanomaterialApplication PCTUS2018040324Pending
Size Selection Purification Using A Thermoplastic Silica NanomaterialApplication 62527659Pending

LIFESENSORS, INC.Similar federal contract value in Biotech · $24K in contracts
Harvard Apparatus Regenerative Technology, Inc.Similar federal contract value in Biotech · $22K in contracts
TriSalus Life Sciences, Inc.Similar federal contract value in Biotech · $22K in contracts
ORPHAGEN PHARMACEUTICALS, INC.Similar federal contract value in Biotech · $15K in contracts
CHEMBIND LLCSimilar federal contract value in Biotech · $15K in contracts
BioCardia, Inc.Similar federal contract value in Biotech · $15K in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.